LIMK1 and non-small cell lung carcinoma: The extent of PAK4 upregulation was positively correlated with the amount of p-LIMK1 (R2 = 0.657, p < 0.05) (Fig. 5e), suggesting that the effect of PAK4 kinase activity on LIMK1 is clinically relevant in human NSCLC tissues.